Capecitabine/cisplatin versus 5 ‐fluorouracil/cisplatin in Chinese patients with advanced and metastatic gastric cancer: Re‐analysis of efficacy and safety data from the ML17032 phase III clinical trial
Asia-Pacific Journal of Clinical Oncology, EarlyView.
Source: Asia-Pacific Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Clinical Trials | Gastric (Stomach) Cancer | Gastroenterology | Xeloda